Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 5,000 shares at $102.28 ($511K) on 2025-01-13, disclosed to the SEC on 2025-01-15.
Scheduled sale ($511k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |